AUSTRALIAN PREDICTING INFECTIOUS COMPLICATIONS IN CHILDREN WITH CANCER (PICNICC) PROJECT
Grant number: 1104527 | Funding period: 2016 - 2019
Children undergoing cancer treatment are at an increased risk of infection. This is managed by admission to hospital for antibiotics which can be a frightening experience for the child, disruptive for their family and expensive for the healthcare system. While many need admission, a proportion of patients can be safely managed at home with oral or intravenous antibiotics. This project aims to identify these children, so as to improve their quality of life, and decrease cost of treatment.
Related publications (5)
Aminoglycoside use in paediatric febrile neutropenia - Outcomes from a nationwide prospective cohort study
Brendan J McMullan, Gabrielle M Haeusler, Lisa Hall, Louise Cooley, Andrew J Stewardson, Christopher C Blyth, Cheryl A Jones, Pamela Konecny, Franz E Babl, Francoise Mechinaud, Karin Thursky
Aminoglycosides are commonly prescribed to children with febrile neutropenia (FN) but their impact on clinical outcomes is uncerta..
Home-based care of low-risk febrile neutropenia in children-an implementation study in a tertiary paediatric hospital
Gabrielle M Haeusler, Lynda Gaynor, Benjamin Teh, Franz E Babl, Lisa M Orme, Ahuva Segal, Francoise Mechinaud, Penelope A Bryant, Bob Phillips, Richard De Abreu Lourenco, Monica A Slavin, Karin A Thursky
BACKGROUND: Home-based management of low-risk febrile neutropenia (FN) is safe, improves quality of life and reduces healthcare ex..
Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia.
Gabrielle M Haeusler, Robert Phillips, Monica A Slavin, Franz E Babl, Richard De Abreu Lourenco, Francoise Mechinaud, Karin A Thursky, null Australian PICNICC study group and the PREDICT network
Background: Numerous paediatric febrile neutropenia (FN) clinical decision rules (CDRs) have been derived. Validation studies show..
Diagnostic Yield of Initial and Consecutive Blood Cultures in Children With Cancer and Febrile Neutropenia.
Gabrielle M Haeusler, Richard De Abreu Lourenco, Hannah Clark, Karin A Thursky, Monica A Slavin, Franz E Babl, Francoise Mechinaud, Frank Alvaro, Julia Clark, Bhavna Padhye, Marianne Phillips, Leanne Super, Heather Tapp, Thomas Walwyn, David Ziegler, Robert Phillips, Leon J Worth
BACKGROUND: The timing and necessity of repeated blood cultures (BCs) in children with cancer and febrile neutropenia (FN) are unk..
Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules.
Gabrielle M Haeusler, Karin A Thursky, Monica A Slavin, Franz E Babl, Richard De Abreu Lourenco, Zoe Allaway, Francoise Mechinaud, Robert Phillips, null Australian PICNICC study group and the PREDICT network
Background: Reduced intensity treatment of low-risk febrile neutropenia (FN) in children with cancer is safe and improves quality ..